Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic Cancer
Clinical trial NCT05202314 · RECRUITING
Trial details
- NCT number
- NCT05202314
- Sponsor
- Beijing Chao Yang Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-12
- Primary completion
- 2023-12-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.